Histoplasma capsulatum is a thermally dimorphic ascomycete found globally in rich soils, often associated with high concentrations of bird guano. H. capsulatum is the causative agent of the mammalian disease histoplasmosis. Histoplasmosis is highly endemic in the Ohio and Mississippi River valleys of the United States, where up to 90% of the population shows a positive delayed-type hypersensitivity reaction in skin tests with H. capsulatum antigen (8) . Humans and other mammals are infected by inhalation of microconidia or mycelial fragments small enough to be deposited in the lung alveoli. There the mold undergoes a morphogenic transition to the yeast form that survives and replicates within host macrophages. The identities of specific virulence factors of pathogenic fungi have been particularly elusive. Some of the fungal virulence factors identified to date include proteases, such as the secreted aspartyl proteases from Candida albicans (20, 22) . Extracellular proteolytic activity has been described previously in H. capsulatum and shown to hydrolyze casein, bovine serum albumin, and collagen (21, 23, 24, 30) . However, H. capsulatum protease genes have not been identified.
Dipeptidyl peptidases are exoproteases that cleave dipeptides from proteins. Types of dipeptidyl peptidases differ in substrate specificity. Dipeptidyl peptidase type IV (DppIV) enzymes cleave dipeptides from the N termini of proteins after a proline or, less efficiently, alanine in the second position, releasing X-Pro and X-Ala dipeptides. DppIV enzymes show a wide evolutionary distribution, with members present in bacteria, fungi, protozoans, and mammals. The best-characterized type IV enzyme is human CD26. CD26 is a type II plasma membrane glycoprotein with major roles in immune regulation. CD26 removes X-Pro and X-Ala dipeptides from substrates such as chemokines, neuropeptides, and hormones and by doing so regulates substrate activity (9, 15, 16, 19) . CD26 also interacts with collagen and fibronectin and exhibits activity against denatured collagens, indicating a possible role in collagen metabolism (3) . Bacterial DppIV enzymes play roles in nutrient acquisition and virulence (14, 27) . Fungal DppIV enzymes include the ␣ mating factor processing enzyme DPAPA and the vacuolar DPAPB enzyme from Saccharomyces cerevisiae (6, 7) . DppIV enzymes from filamentous fungi are secreted, such as DppIV from Aspergillus fumigatus (2) , or intracellular, such as DapB from A. niger (11) . A. fumigatus DppIV is antigenic and has been postulated to be involved in pathogenesis (2) . Here, we describe the identification in H. capsulatum of secreted DppIV activity, as well as two putative contributory genes, HcDPPIVA and HcDPPIVB.
MATERIALS AND METHODS

Strains and media.
H. capsulatum strains G217B, G217Bura5-23, G186AR, G186AS, G184AR, G184AS, Downs, UCLA 531S, UWclin01, and UWclin03 were used in these studies (4) . Strain ⌬KU70/⌬KU80 will be described elsewhere (K. G. Cooper and J. P. Woods, submitted for publication). Escherichia coli JM109 grown in Luria-Bertani broth was used for cloning and propagation of plasmids. H. capsulatum was maintained in the yeast form in Histoplasma macrophage medium (HMM) at 37°C as previously described (28) . When indicated, the mycelial form was grown at 22°C. Adenine or uracil was added as a supplement at 100 g/ml when needed. G418 and nourseothricin were used for selection at concentrations of 200 g/ml and 50 g/ml, respectively. Plasmids were transformed by electroporation into H. capsulatum strains as previously described (28) . RAW 264.7 cells, a murine macrophage-like cell line (ATCC TIB-71), were used in this study. RPMI medium (Cellgro, Herndon, VA) supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA) was used for propagation of RAW 264.7 cells at 37°C. Adenine was added at 100 g/ml during infection of macrophages to complement ADE2 inactivation chemically.
Fungal supernatant preparation. H. capsulatum culture supernatants were harvested by pelleting cells at 1,200 ϫ g for 10 min at 24°C. Supernatants were filtered with 0.22-m polyethersulfone membranes and concentrated 15 to 30ϫ with regenerated cellulose filter devices with a molecular mass cutoff of 5 kDa (Millipore, Bedford, MA). The total protein concentration was determined with the Bradford assay (Bio-Rad, Hercules, CA).
Microtiter plate DppIV enzymatic assay. A 90-l volume of each supernatant was added to 96-well plates. A 10-l volume of either Gly-pro-7-amido-4-methylcoumarin hydrobromide (Gly-pro-AMC) or Arg-pro-p-nitroanilide (Arg-propNA) was added for a final concentration of 200 M (Sigma, St. Louis, MO). Samples were incubated at 37°C with shaking. Enzymatic cleavage leading to release of the fluorescent AMC molecule was measured with a microplate spectrofluorometer (SPECTRAmax Gemini EM; Molecular Devices) with excitation and emission wavelengths of 360 and 440 nm, respectively. The release of the chromogenic pNA molecule was measured by determining absorbance at 405 nm with a microplate spectrophotometer (SPECTRAmax 250; Molecular Devices). Wells containing only medium mixed with substrate were used as blanks for subtraction from measured values. Values were normalized to the total protein concentration. Triplicate wells were used for each sample.
Statistics. Statistical significance was evaluated with Prism (GraphPad Software, San Diego, CA). Unpaired t tests were done with two-tailed P values and 95% confidence intervals.
Bioinformatic analysis. Putative DPPIV homologs were identified by querying the H. capsulatum G217B genomic database (http://www.genome.wustl.edu) with the DppIV protein sequence from A. fumigatus and then further analyzed by genomic and cDNA PCR and sequencing. H. capsulatum DPPIVA and DPPIVB sequence data have been submitted to the GenBank database (accession numbers pending). Human and various fungal DppIV homolog sequences were collected from the Entrez PubMed protein database. The C-terminal 200-residue regions which contain the highest similarity, as well as the catalytic triad, were aligned with ClustalX (http://www.ebi.ac.uk/clustalw/index.html). PHYLIP protdist (http: //mobyle.pasteur.fr/cgi-bin/portal.py?formϭprotdist) was used to build a neighborjoining phylogenetic tree in which a bootstrap analysis (100 replicates) was performed. The resulting tree was viewed with the Phylodendron phylogenetic tree printer (http://www.es.embnet.org/Doc/phylodendron/treeprint-form.html). Putative signal sequences and transmembrane domains were identified with SignalP 3.0 (http://www.cbs.dtu.dk/services/SignalP/) and TMHMM 2.0 (http://www.cbs.dtu.dk /services/TMHMM/).
Preparation of H. capsulatum cDNA. RNA was collected from log-phase cultures of G217B with TRIzol Reagent (Invitrogen) by following the manufacturer's instructions. Contaminating DNA was removed by treatment with amplification grade DNase I (Invitrogen). Reverse transcription reactions were carried out with the SuperScript First-Strand Synthesis System (Invitrogen) by following the manufacturer's protocol.
PCR. PCR amplification was performed with the TripleMaster high-fidelity PCR system (Eppendorf, Westbury, NY) by following the manufacturer's instructions. All primers were designed from sequences obtained from the H. capsulatum G217B genomic database (http://www.genome.wustl.edu) with MacVector sequence analysis software (Accelrys). Primers were synthesized by Integrated DNA Technologies (Coralville, IA).
Targeted silencing in G217Bura5-23 by RNA interference (RNAi). We used an H. capsulatum expression vector (pLBZ-1) described previously (31) . It carries a PaURA5 marker for selection, an inverted telomeric region for linearization and maintenance, and cloning sites between the H2B 5Ј and CATB 3Ј flanking sequences. A sentinel hairpin approach was used to target both the gene of interest and ADE2 for easy phenotypic screening (Cooper and Woods, submitted). ADE2, which encodes a phosphoribosylamino-imidazole-carboxylase, was used as the sentinel because of the characteristic red pigmentation resulting from ADE2 inactivation. Plasmid p-ade2, targeting ADE2 for RNAi, will be described elsewhere (Cooper and Woods, submitted). pA-ade2 and pB-ade2 were designed to target HcDPPIVA/ ADE2 or HcDPPIVB/ADE2, respectively, for sentinel RNAi (see Fig. 3A ). To construct pA-ade2, 2,105-bp fragments of HcDPPIVA were amplified from cDNA and cloned in the opposite orientations into the AscI and SbfI sites of p-ade2 as follows. The first fragment was amplified and cloned into the AscI sites with primers 5Ј-NNNGGCGCGCCACGCGTACTGGAGGCGGAAAAAGACTTC-3Ј (da-1) and 5Ј-NNNGGCGCGCCGTAAACCACTGCGACTCCATCTTC-3Ј (da-2), where the boldface sequences represent restriction sites used in cloning. The second fragment was amplified and cloned in the opposite orientation into the SbfI site with primers 5Ј-NNNNNNCCTGCAGGATGCATACTGGAGGCGGAAAAAGA CTTC-3Ј (da-3) and 5Ј-NNNNNNCCTGCAGGGTAAACCACTGCGACT CCATCTTC-3Ј (da-4). The correct orientation was confirmed by PCR with external primers or by diagnostic restriction digestion. The entire double-hairpin sequence was then excised by using the introduced MluI and NsiI sites (underlined) and cloned into the compatible AscI and SbfI sites of pLBZ-1. pB-ade2 was designed and constructed the same way as pA-ade2 with the following primers. The first 2,069-bp fragment was amplified with primers 5Ј-NNNGGCGCGCCACGCGTTTCAGGAGC-CACGACACATACC-3Ј (ba-1) and 5Ј-NNNGGCGCGCCGGTGTTGGAAAT-AGCGGAACTG-3Ј (ba-2). The second 2,069-bp fragment was amplified with primers 5Ј-NNNNNNCCTGCAGGATGCATTTCAGGAGCCACGACACATACC-3Ј (ba-3) and 5Ј-NNNNNNCCTGCAGGGGTGTTGGAAATAGCGGAACTG-3Ј (ba-4).
Transformants were selected for uracil prototrophy on HMM plates containing adenine. Colonies were grown on a master HMM plate supplemented with adenine. Each transformant was then patched to an HMM plate without adenine supplementation to analyze the phenotypic effect of ADE2 silencing. Transformants displaying poor growth and red pigmentation when adenine was not present in the medium were identified.
Disruption of HcDPPIVA. The DPPIVA deletion construct was assembled as follows. A 1,718-bp 5Ј flanking DNA fragment was amplified with primers 5Ј-NNNCTCGAGGCTAGCTCCTTACAGCCACGGTTTTGTC-3Ј (dppivA-1) and 5Ј-NNNGGATCCTCGTTTGCTTTGCCAGACTTG-3Ј (dppivA-2) and cloned into the XhoI and BamHI sites of pBluescript SKϩ. Next, 1,916 bp of 3Ј flanking DNA was amplified with primers 5Ј-NNNGGATCCAGATTCATCAGTGGAG TCGGAGG-3Ј (dppivA-3) and 5Ј-NNNNNNGCGGCCGCGCTAGCCGCAAC TACCAATCCCATCTATG-3Ј (dppivA-4) and cloned into the plasmid at the BamHI and NotI sites. A G418 resistance cassette (H2B promoter, neo, CATB terminator) was constructed by cloning neo from transposon Tn5 into pLBZ-1. This cassette was excised from pLBZ-1 with BamHI and cloned into the BamHI site of the DPPIVA deletion construct. The orientation of the neo gene in the cassette was determined by PCR to be the same as that of the DPPIVA flanking regions. NheI sites were included on the flanking primers (underlined) to facilitate the excision of the replacement DNA. After digestion with NheI, the replacement construct was used to electroporate a strain deficient in the nonhomologous end-joining components Ku70 and Ku80 (⌬KU70/⌬KU80) (Cooper and Woods, submitted). Transformants were selected for resistance to G418. Screening of putative HcDPPIVA deletion mutants was done by diagnostic PCR and Southern blot analysis.
Targeted RNAi silencing in a ⌬HcDPPIVA mutant. To move pB-ade2 into the ⌬HcDPPIVA mutant, we used nourseothricin resistance as a selectable marker. The Streptomyces noursei nourseothricin acetyltransferase gene (nat) (18) was cloned into pLBZ-1 between the H2B promoter and the CATB terminator. This entire expression cassette was then amplified by PCR and cloned into the NsiI sites of pB-ade2 or empty pLBZ-1 to construct pB-ade2-nat and pLBZ-nat, respectively. Both pB-ade2-nat and pLBZ-nat were transformed into the ⌬HcDPPIVA mutant. Transformations were plated on HMM plates containing nourseothricin.
Growth analysis. Yeast cells were taken from late-log-phase cultures, adjusted to an optical density at 600 nm of 0.4, diluted 1:100 in HMM, and then grown with agitation in Klett flasks at 37°C. Culture turbidity was measured with a photoelectric colorimeter (Manostate Corporation, New York, NY). Adenine was provided at 100 g/ml.
Virulence assays. The virulence of H. capsulatum was evaluated by determining its ability to kill RAW 264.7 cells as previously described (5, 26) . Briefly, RAW 264.7 cells were seeded into 96-well culture plates at a density of 2 ϫ 10 4 /well. The cells were incubated at 37°C overnight to allow adherence. Two-day H. capsulatum cultures were diluted in complete RPMI medium with or without adenine and added to macrophages at a multiplicity of infection of five yeast cells per macrophage. After 4 h of incubation at 37°C, the wells were washed twice in serum-free RPMI medium to remove extracellular H. capsulatum. Fresh complete RPMI medium with or without adenine was added to the wells, and the infection proceeded for 4 days at 37°C. Extracellular H. capsulatum was washed away with serum-free RPMI medium, and the viability of RAW 264.7 cells was measured by determining bromodeoxyuridine incorporation (Roche). The colorimetric proliferation assay was carried out according to the manufacturer's instructions. Absorbance was measured at 370 nm. Wells containing uninfected cells were set at 100% viability, and wells containing no cells were set at 0% viability.
RESULTS
DppIV activity in H. capsulatum culture supernatant. To test for the presence of secreted DppIV enzyme(s), culture supernatant fractions from several strains of H. capsulatum were incubated in the presence of a synthetic substrate (Gly-pro-AMC) that fluoresces when the pro-X bond is cleaved and AMC is released. After addition of Gly-pro-AMC, fluorescence was detected in culture supernatant fractions but not in media, indicating that a component with DppIV activity is secreted from H. capsulatum. Heating supernatant fractions to 100°C before the assay abolished all activity. The activity was also inhibited by the DppIV-specific inhibitors diprotin A and H-Glu-(NHO-Bz)-Pyr, suggesting that a DppIV enzyme(s) is responsible (data not shown). Supernatants of all of the strains of H. capsulatum tested exhibited some level of DppIV activity, indicating this activity is conserved across all three major restriction fragment length polymorphism (RFLP) classes (Fig.  1) . We observed substantial differences in secreted activity between strains, particularly between rough and smooth variants of two different strain lineages. These variants differ in cell wall ␣-1,3-glucan and exposure of ␤-1,6-glucan. Differences in protein secretion and culture supernatant composition have not been reported for these variants, to our knowledge, and we have not further pursued these differences. DppIV activity was detected for the single strain of H. capsulatum var. duboisii we tested, although it was the lowest among the strains tested.
H. capsulatum contains two putative DPPIV genes. We named these putative proteins HcDppIVA and HcDppIVB, respectively. Both HcDppIVA and HcDppIVB showed the most sequence similarity to DppIV family members within the C-terminal portion of the proteins, which contains the conserved catalytic triad residues ( Fig. 2A) . The predicted HcDPPIVA gene contains two exons, one of which is only nine bases in length, which we confirmed by cDNA sequencing (data not shown). The corresponding ORF of the enzyme has 777 amino acids and includes a putative signal sequence and several predicted N-glycosylation sites. HcDppIVB does not have a putative secretory signal sequence but does contain one transmembrane domain near the N terminus, as predicted by TMHMM analysis (data not shown). The predicted HcDppIVB ORF is composed of two exons that yield a protein of 895 residues. These sequence data have been submitted to the GenBank database (accession numbers pending). To determine the evolutionary relationship of H. capsulatum DppIV enzymes to other fungal DppIV family members, a comparative molecular analysis was performed with the 200 C-terminal residues of available fungal DppIV sequences. The resulting tree revealed that HcDppIVA is most closely related to extracellular DppIV enzymes, while HcDppIVB is similar to the DapB-like members (Fig. 2B) . HcDPPIVA does not encode most of the secreted DppIV activity of H. capsulatum. Based on the phylogenetic analysis and the presence of a predicted signal sequence, we hypothesized that HcDppIVA is responsible for the secreted DppIV activity in H. capsulatum supernatants. We tested this prediction by attempting to silence HcDPPIVA by sentinel RNAi in H. capsulatum. The ADE2 gene encoding phosphoribosylamino-imidazole-carboxylase was chosen as the sentinel because of the characteristic red pigmentation that results from ADE2 inactivation. RNAi plasmids in which either ADE2 or both ADE2 and HcDPPIVA sequences are flanked by the heterologous H2B promoter and CATB terminator sequences were constructed with pLBZ-1. Plasmids p-ade2 and pA-ade2 (Fig. 3A) were constructed and used to transform H. capsulatum strain G217Bura5-23. Transformants were selected for uracil prototrophy on plates containing adenine. To determine whether each transformant had an ADE2-silenced phenotype, colonies were picked and patched to plates without adenine as described elsewhere (Cooper and Woods, submitted). Silencing of ADE2 was quite effective, with 49/50 tested transformants displaying red color and poor growth without adenine. We picked four transformants that displayed an ADE2-silencing phenotype from each transformation and tested for secreted DppIV activity with Arg-pro-pNA. Compared with control strains targeting only ADE2, HcDPPIVA-silenced strains showed no abrogation of levels of secreted DppIV activity (Fig. 3B) .
Deletion of HcDPPIVA. RNAi in H. capsulatum can often be inefficient or highly variable (5, 25, 31) , and so we disrupted HcDPPIVA (Fig. 4A) . Consistent with the RNAi results (Fig.  3B) , we saw no abrogation of supernatant DppIV activity in a strain with HcDPPIVA disrupted (Fig. 3B and 4) , indicating further that this gene does not contribute to secreted DppIV activity. The ⌬HcDPPIVA mutant did not have a growth defect or altered secreted DppIV activity under a variety of environmental conditions in which we might expect HcDPPIVA to be upregulated based on observations of other organisms, such as in wheat gluten-containing media (10; data not shown). Additionally, the ⌬HcDPPIVA mutant was able to convert normally to the mold phase of growth. Levels of secreted DppIV activity were comparable to those of parent strains under all of the conditions tested, including during the mold phase of growth (data not shown). We measured and found no difference in intracellular DppIV activity in cell lysates from the parent and ⌬HcDPPIVA mutant strains (data not shown). HcDPPIVB is required for secreted DppIV activity. Although HcDppIVB is not predicted to contain a secretion signal and is more closely related to intracellular homologs, we tested whether this gene could be responsible for secreted DppIV activity in H. capsulatum. We targeted HcDPPIVB for silencing by sentinel RNAi. A plasmid targeting both ADE2 and HcDPPIVB was constructed (pB-ade2) and electroporated into G217Bura5-23. Silencing of HcDPPIVB with ADE2 was also highly effective, with 25/26 tested transformants displaying a red phenotype when grown without adenine. Unexpectedly, HcDPPIVB-silenced transformants displayed significantly less DppIV activity (ϳ75 to 80% reduction) in supernatants than did transformants with only ADE2 silenced (Fig. 3B) . These data indicate that HcDPPIVB encodes most of the secreted DppIV activity in H. capsulatum.
In order to determine whether HcDPPIVA contributes to the remaining 20 to 25% of the activity observed in HcDPPIVBsilenced strains, we targeted HcDPPIVB for RNAi in the HcDPPIVA-null strain. A nourseothricin resistance cassette was cloned into pB-ade2 to use as a selectable marker in the ⌬HcDPPIVA mutant (Fig. 5A) . Silencing appeared not as effective with this plasmid in the ⌬HcDPPIVA mutant, as demonstrated by the fact that only 2/11 tested transformants displayed a red phenotype in limiting adenine (data not shown). When these two strains were tested for secreted DppIV activity, we observed an about 75% reduction in secreted DppIV activity (Fig. 5B) , similar to HcDPPIVB silencing in G217Bura5-23 (Fig. 3) , indicating that the remaining activity is not due to HcDPPIVA. Effect of HcDPPIVB silencing on H. capsulatum virulence in macrophages. Strains silenced for HcDPPIVB, as well as ADE2, grew similarly to the parent and control strains when adenine was added to the medium in vitro (Fig. 6A) . We infected the murine macrophage-like cell line RAW 264.7 with H. capsulatum ADE2-silenced strains and HcDPPIVB/ADE2-silenced strains to evaluate the role of HcDPPIVB in virulence. ADE2 is required for virulence; however, the addition of exogenous adenine to the medium is able to chemically complement ADE2 deficiency in this model (Cooper et al., unpublished data). ADE2-silenced strains were unable to kill macrophages without adenine, providing a sentinel for continued RNA silencing during the virulence assay (data not shown). When adenine was supplied in the medium, ADE2-silenced strains were able to kill ϳ75% of the macrophages, which was similar to the amount of killing by the parental control. Strains with ADE2 or both ADE2 and HcDPPIVB inactivated showed virtually identical abilities to kill macrophages (Fig. 6B ), indicating that HcDPPIVB is not required for virulence in this model. However, we did not measure the specific steps of internalization and the subsequent intracellular growth rate, and so we cannot address the possibility of a defect in one and a compensatory increase in the other.
DISCUSSION
We identified two putative DppIV homologs in the H. capsulatum genome, HcDPPIVA and HcDPPIVB. Phylogenetic analysis indicates that HcDppIVA falls within a group of DppIV enzymes that are secreted in other fungal species, while HcDppIVB clusters with intracellular enzymes. Additionally, This is the first study of DppIV activity in human pathogenic dimorphic fungi. Secreted DppIV enzymes are possible candidates for virulence factors because of their potential for cleaving host substrates. The bacterium Porphyromonas gingivalis encodes an extracellular DppIV enzyme that is involved in host tissue destruction and host immune cell recruitment (13, 29) . The fungus A. fumigatus secretes a DppIV enzyme that is antigenic and can cleave host substrates such as neuropeptide Y, bradykinin, and glucagon-like peptide 1 (2) . Trichophyton spp. secrete DppIV enzymes that are upregulated during skin infection (12) .
The H. capsulatum genome contains sequences predicted to encode both a secreted and an intracellular DppIV enzyme. This situation is similar to what is observed in filamentous fungi, whereas yeasts such as S. cerevisiae possess only cellassociated DppIV enzymes. However, in this study we demonstrated that the closest H. capsulatum homolog of A. fumigatus DppIV, HcDppIVA, is not responsible for most of the secreted DppIV activity. Furthermore, the predicted intracellular DapB homolog HcDppIVB is responsible for the secreted activity. Although it may be considered unusual for a protein without a predicted secretion signal to have an extracellular location, it is not the first such occurrence. Other predicted intracellular proteins in H. capsulatum have been found on the cell surface, such as HSP60 (17) . Additionally, H. capsulatum secretes membrane-bound vesicles into culture supernatant that contain intracellular proteins (1). It is possible that HcDppIVB is contained within these vesicles and subsequently released or inserted into the membrane of these vesicles by the predicted transmembrane domain found within its N terminus.
RNAi targeting HcDPPIVB resulted in an ϳ75% reduction in secreted DppIV activity. When HcDPPIVB was silenced in the HcDPPIVA-null strain, we saw a similar reduction in secreted activity, indicating that HcDPPIVA does not contribute to the remaining 25%. We hypothesize that the remaining activity is a nonspecific effect due to another component of H. capsulatum supernatant; however, it is possible that we were unable to detect a contribution by HcDPPIVA. For example, it is possible that targeting HcDPPIVB by RNAi was more efficient in strain G217Bura5-23 than in the ⌬HcDPPIVA mutant and that this difference masked the contribution of HcDPPIVA. Further studies characterizing HcDPPIVA and its gene product will help to elucidate the role of this gene in H. capsulatum biology, along with any functions it may have that overlap those of HcDPPIVB.
Our results with RNAi indicate that HcDPPIVB is not required for virulence of H. capsulatum when infecting a macrophage-like cell line. However, if secreted DppIV activity in H. capsulatum plays a role during infection similar to that in P. gingivalis, namely, cleavage of host immunomodulatory peptides, the effects of removing HcDPPIVB would most likely be more important in a whole-animal model of infection. We were unable to test HcDPPIVB-silenced strains in a mouse model of infection due to the sentinel inactivation of ADE2, a gene that is important for H. capsulatum infection in macrophages and mice (Cooper et al., unpublished data). Targeting HcDPPIVB for gene deletion would allow an evaluation of the role this gene has during the infection of mammalian hosts.
